Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe Taiwan location entry Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the study's list of sites, updating the geographic coverage in Taiwan.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s displayed application/version revision updates from v3.5.0 to v3.5.3, reflecting a software release without changing the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision tag updated to v3.4.3, replacing the prior v3.4.2.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 is now displayed on the page, and the previous funding-status notice as well as Revision: v3.4.1 have been removed. No study content, eligibility criteria, or user actions are affected by this change.SummaryDifference0.3%

- Check98 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, informing users that the NIH Clinical Center is open and linking to cc.nih.gov and opm.gov for status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.